Virtu Financial LLC Scynexis Inc Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$1.39 - $2.21 $18,949 - $30,128	13,633 New	13,633 $20,000
Q3 2023 Nov 14, 2023	BUY	$1.93 - $3.64 $79,639 - $150,200	41,264 New	41,264 $94,000
Q3 2022 Nov 07, 2022	BUY	$1.83 - $2.93 $58,195 - $93,176	31,801 New	31,801 $76,000
Q1 2022 May 17, 2022	SELL	$3.56 - $6.66 $52,011 - $97,302	-14,610 Closed	0 $0
Q4 2021 Feb 17, 2022	SELL	$4.94 - $7.69 $11,841 - $18,432	-2,397 Reduced 14.09%	14,610 $89,000
Q3 2021 Nov 12, 2021	BUY	$5.3 - $7.89 $13,674 - $20,356	2,580 Added 17.88%	17,007 $90,000
Q2 2021 Sep 17, 2021	BUY	$6.5 - $9.97 $93,775 - $143,837	14,427 New	14,427 $106,000
Q1 2021 May 19, 2021	SELL	$6.93 - $9.63 $178,696 - $248,319	-25,786 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$4.28 - $7.87 $110,364 - $202,935	25,786 New	25,786 $197,000

13.7M

21.9K

2.6K

Ticker SCYX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 32,651,800
Market Cap $33M
Description
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.